More evidence is needed to establish the relationship between SIRT1 concentration and activity, its role in the progression of peritoneal fibrosis, and its potential as a biomarker for both cardiovascular and renal complications in CKD patients. The gene discussed is SIRT1; the disease is chronic kidney disease.